首页>Liver International>Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: 'Lead-in or no lead-in'?
Triple combination treatment for chronic hepatitis C with Protease Inhibitors, pegylated interferon and ribavirin: 'Lead-in or no lead-in'?
作者单位：Department of Hepatology, Queen Mary University of London, London, United Kingdom[1]Service d'Hépatologie, H?pital Saint-Antoine, Université Pierre and Marie Curie, Paris, France[2]
换一批
